Icahn accuses Forest of hiding poison pill pacts

Activist investor Carl Icahn, engaged in a bitter proxy battle with Forest Laboratories, accused the drugmaker of hiding information from shareholders that might show it has provisions built into its licensing agreements that would deter a potential suitor. Icahn said on Friday he had asked a Delaware court to allow him to release non-public information to shareholders.

Please read our terms of use before posting comments
TERMS OF USE: The views expressed in comments published on indianexpress.com are those of the comment writer's alone. They do not represent the views or opinions of The Indian Express Group or its staff. Comments are automatically posted live; however, indianexpress.com reserves the right to take it down at any time. We also reserve the right not to publish comments that are abusive, obscene, inflammatory, derogatory or defamatory.